Description:Ferment is a pioneering company creation studio that focuses on the development of the next generation of synthetic biology product companies. The organization's mission is to incubate, fund, and launch innovative new ventures that harness the power of programmed biology to influence and enhance the future of humanity.
With a collaborative approach, Ferment unites founders, bioplatforms, corporate strategic partners, and investors to build companies that address a diverse array of end markets, including food, agriculture, personal care, animal health, and waste remediation. This multifaceted strategy not only fosters creativity and innovation but also positions Ferment as a key player in the rapidly evolving landscape of synthetic biology.
To date, Ferment has successfully launched six companies, which have collectively raised an impressive total of $630 million from both financial and strategic investors. This track record underscores Ferment's commitment to driving impactful change through synthetic biology, while also demonstrating its ability to attract significant investment and support from various stakeholders who share a vision for a sustainable and advanced future.